麻杏甘石湯合清冠一號治療COVID-19肺炎合併症案例

Cases of Ma-Xing-Gan-Shi-Tang and NRICM101 in the Treatment of COVID-19 Pneumonia Comorbidities

黃柏銘(Bo-Ming Huang)

《中醫藥研究論叢》 25卷特刊 (2022/03) Pp. 43-50

https://doi.org/10.6516/TJTCM.202203/SP_25.0006

摘要

新冠肺炎（COVID-19）疫情侵擾全球超過2年，病毒變異變型快速，除發燒頭痛、呼吸道症狀，尚有疲累、味嗅覺異常等等病症發現。中醫溫病揭示“溫邪上受，首先犯肺”，符合現今COVID-19肺炎感染情況，本文以氣分溫病併發肺炎的證治，麻杏甘石湯合清冠一號中藥宣肺清火，緩解新冠肺炎邪熱壅肺的案例。

關鍵字

麻杏甘石湯 ； 魚腥草 ； 中醫溫病 ； 新冠肺炎 ； 清冠一號

並列摘要

The COVID-19 pneumonia epidemic has invaded the world for more than 2 years. The virus mutates rapidly. In addition to fever, headache, respiratory symptoms, fatigue, abnormal taste and smell, and other symptoms have been found. Traditional Chinese medicine for febrile disease reveals that ＂warming pathogens are the first to infect the lungs＂, which is in line with the current situation of COVID-19 pneumonia. Taking Ma-Xing-Gan-Shi-Tang (MXGST) with NRICM101 to relieve the case of COVID-19 pneumonia from the evil heat of lung and heart pattern.

並列關鍵字

Ma-Xing-Gan-Shi-Tang (MXGST) ； Houttuynia Cordata ； Eepidemic Febrile Disease of Traditional Chinese medicine ； COVID-19 ； NRICM101

參考文獻

衛生福利部國家中醫藥研究所（2020）：《新型冠狀病毒病中醫臨床分期治療指引》公告。中醫藥雜誌，31(1)：1-3。DOI:10.6940/JCM.202006_31(1).01

Cheng HY, Jian SW, Liu DP, Ng TC, Huang WT, Lin HH (2020). Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset, JAMA Internal Medicine, 180(9): 1156, DOI:10.1001/jamainternmed.2020.2020

Kao ST , Yeh TJ, Hsieh CC, Shiau HB, Yeh FT, Lin JG (2001).The Effects of Ma-Xing-Gan-Shi-Tang on Respiratory Resistance and Airway Leukocyte Infiltration in Asthmatic Guinea Pigs. Immunopharmacol Immunotoxicol, 23(3): 445-58, DOI: 10.1081/iph-100107343

王哲義、孫懌澤、曲稔棟、劉碧原、樊竹、田金洲、盧濤（2020）：基於網路藥理學的麻杏石甘湯治療新型冠狀病毒肺炎（COVID-19）作用機制探討。中草藥，51(8)：1996-2003。DOI:10.7501/j.issn.0253-2670.2020.08.003

葉天士述：顧景文等人寫錄（1746）。溫熱論（華岫雲本）。